Toggle light / dark theme

Novel Ultra-Thin Sensor Records Brain Activity in Record-Breaking Resolution

A team of engineers and neurosurgeons developed a state-of-the-art brain sensor that could greatly enhance the treatment of cancer and epilepsy, according to a press statement from the University of California San Diego.

The new apparatus can record electrical signals from the brain’s surface in a never-before-seen resolution for such a device.

The breakthrough opens up new possibilities for brain-computer interfaces, such as the ones being developed by Elon Musk’s Neuralink. Not only will this help to improve diagnoses of deadly diseases, it also has the potential to transform our understanding of the human brain.

New Gene Sequencing Method Cuts Cost and Is Five Times Faster, Study Says

And it took less than a full workday. Stanford Medicine scientists and their collaborators have engineered a new genome sequencing technique that can diagnose rare genetic diseases in an average of eight hours. This is a record-breaking time frame that is leap and bounds ahead of other current advanced technologies.


Gene sequencing is crucial to advancing science! Check out why cutting time and cost is key.

Researchers successful in healing deep wounds using 3D bioprinted skin

Researchers from the University of Birmingham and the University of Huddersfield, UK, have developed a new 3D bioprinting technique that can be used to treat chronic wounds.

Named Suspended Layer Additive Manufacturing (SLAM), the approach enables the printing of a novel biomaterial that accurately simulates the structure of mammalian skin.

In fact, according to the researchers, the biomaterial is the first of its kind to simulate all three of the major layers found in skin – the hypodermis, the dermis, and the epidermis – making it a unique tri-layered skin equivalent. Early experiments suggest that the 3D bioprinted skin can be placed at the site of a wound to induce healing, reducing scar tissue in the process.

Japan expands quasi-state of emergency

Japan’s government is expanding a quasi-state of emergency aimed at containing the coronavirus. Infections are surging nationwide at an unprecedented pace, largely fueled by the Omicron variant.

Officials confirmed more than 60,000 new cases on Tuesday. The figure is a record high. A total of 444 people are in serious condition, up five from the day before.

More than half of Japan’s 47 prefectures reported record case counts, including Tokyo.

Team demonstrates molecular electronics sensors on a semiconductor chip

The first molecular electronics chip has been developed, realizing a 50-year-old goal of integrating single molecules into circuits to achieve the ultimate scaling limits of Moore’s Law. Developed by Roswell Biotechnologies and a multi-disciplinary team of leading academic scientists, the chip uses single molecules as universal sensor elements in a circuit to create a programmable biosensor with real-time, single-molecule sensitivity and unlimited scalability in sensor pixel density. This innovation, appearing this week in a peer-reviewed article in the Proceedings of the National Academy of Sciences (PNAS), will power advances in diverse fields that are fundamentally based on observing molecular interactions, including drug discovery, diagnostics, DNA sequencing, and proteomics.

“Biology works by talking to each other, but our existing measurement methods cannot detect this,” said co-author Jim Tour, Ph.D., a Rice University chemistry professor and a pioneer in the field of molecular electronics. “The demonstrated in this paper for the first time let us listen in on these molecular communications, enabling a new and powerful view of biological information.”

The molecular electronics platform consists of a programmable semiconductor chip with a scalable sensor array architecture. Each array element consists of an electrical current meter that monitors the current flowing through a precision-engineered molecular wire, assembled to span nanoelectrodes that couple it directly into the circuit. The sensor is programmed by attaching the desired probe molecule to the molecular wire, via a central, engineered conjugation site. The observed current provides a direct, electronic readout of molecular interactions of the probe. These picoamp-scale current-versus-time measurements are read out from the sensor array in digital form, at a rate of 1,000 frames per second, to capture molecular interactions data with high resolution, precision and throughput.

Wingcopter, Spright ink $16 million eVTOL drone delivery deal

US medical drone delivery specialist Spright extends partnership with Germany’s Wingcopter to use its eVTOL UAV exclusively in its fleets.


German drone company Wingcopter and US medical UAV services provider Spright have deepened their relationship with a new deal for electric vertical takeoff and (eVTOL) aerial delivery craft valued at $16 million dollars.

Launched as Air Methods’ specialized UAV unit, Spright seeks to improve healthcare access and minimize supply challenges for customers across the US, operating primarily in remote or rural areas. To do that, the company is developing its sector-specific US delivery network by leveraging its existing infrastructure of more than 300 bases, serving hundreds of hospitals across 48 states.

Dr. Amy Throckmorton, PhD — BioCirc / Drexel University — Innovating Life-Saving Therapeutic Devices

Innovating Life-Saving Therapeutic Devices — Dr. Amy Throckmorton, PhD — BioCirc Research Laboratory, Drexel University School of Biomedical Engineering, Science and Health Systems.


Dr. Amy Throckmorton, Ph.D. (https://drexel.edu/biomed/faculty/core/ThrockmortonAmy/) is Associate Professor and Director of the BioCirc Research Laboratory, in the School of Biomedical Engineering, Science and Health Systems, at Drexel University.

The BioCirc Research Laboratory seeks to improve the treatment strategies and therapeutic options for pediatric and adult patients suffering from acquired or congenital heart disease by developing unique features for inclusion in the design of blood pumps and to develop entirely new designs of blood pumps for patients with single ventricle or biventricular circulations as a bridge-to-transplant, bridge-to-recovery, or destination therapy.

Prior to this position, in the Department of Mechanical and Nuclear Engineering at the Virginia Commonwealth University, Dr. Throckmorton served as Associate Professor and previously held the chaired Qimonda Assistant Professorship.

Dr. Throckmorton received her PhD and MS in Biomedical Engineering, as well as a BS in Chemical Engineering, from the University of Virginia.

Dr Charlotte Yeh, MD — Chief Medical Officer, AARP Services — Building Resilience For Healthy Aging

Building resilience for healthy aging — dr. charlotte yeh, MD, chief medical officer, AARP services.


Dr Charlotte Yeh, MD Chief Medical Officer, AARP Services, Inc. (https://www.aarp.org/about-aarp/aarp-services/), where she works with the independent carriers that make health-related products and services available to AARP members, to identify programs and initiatives that will lead to enhanced care for older adults.

AARP (formerly called the American Association of Retired Persons) is a United States–based interest group focusing on issues affecting those over the age of fifty. According to the organization, it had more than 38 million members as of 2018.

Dr. Yeh has more than 30 years of healthcare experience – as a practitioner and Chief of Emergency Medicine at Newton-Wellesley Hospital and Tufts Medical Center, as the Medical Director for the National Heritage Insurance Company, a Medicare Part B claims contractor, and as the Regional Administrator for the Centers for Medicare and Medicaid Services in Boston.

Dr. Yeh is widely recognized for her commitment to and passion for the healthcare consumer and has received numerous honors for her efforts on behalf of patients. As a health care leader, she has served on numerous boards and committees throughout her career, and currently sits on the Blue Cross Blue Shield of Massachusetts Foundation Board, the Optum Labs Scientific Advisory Board, and the HX360 Executive Leadership Advisory Board.

Elon Musk’s Brain Chip Company Is Preparing to Launch Human Trials

Elon Musk’s brain chip company Neuralink appears to be gearing up to launch its first-ever human trials, with the firm now looking to recruit a director to run the tests.

According to The Guardian, the entrepreneur, who owns a variety of science-based start-ups, is preparing to take Neuralink’s brain chip research to the next stage by hiring a mission-driven Clinical Trial Director to begin human testing. The company is moving toward potentially finding a way to use the technology to treat people with brain and spinal injuries.